ECP
PTX

Elk Creek Partners’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Elk Creek Partners’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-230,895
Closed -$2.42M – 157
2016
Q1 		$2.42M Buy
230,895
+5,528
+2% +$110K 0.18% 120
2015
Q4 		$6.65M Buy
225,367
+38,915
+21% +$1.18M 0.47% 83
2015
Q3 		$5.89M Buy
186,452
+22,808
+14% +$1.09M 0.48% 82
2015
Q2 		$9.69M Buy
163,644
+65,783
+67% +$4.64M 0.87% 39
2015
Q1 		$10.5M Buy
97,861
+50,411
+106% +$4.8M 1.09% 22
2014
Q4 		$4.46M Buy
47,450
+18,378
+63% +$1.75M 0.57% 72
2014
Q3 		$2.23M Buy
+29,072
New +$2.29M 0.58% 94

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Elk Creek Partners's PTX Position: Q2 2016 in Review

Elk Creek Partners sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 230,895 shares — an estimated $2.42M sold.

Elk Creek Partners first reported a position in PTX in Q3 2014 and held it in 7 quarters. The position peaked at $10.5M in Q1 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

  • Elk Creek Partners reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • Elk Creek Partners sold 230,895 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $2.42M.
  • Elk Creek Partners first reported a position in Pernix Therapeutics Holdings, Inc. in Q3 2014 and held it in 7 quarters.
  • Elk Creek Partners's Pernix Therapeutics Holdings, Inc. position peaked at $10.5M in Q1 2015.
  • 56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Elk Creek Partners's 13F filing for Q2 2016, filed 12 Aug 2016.